Article
Lack of benefit of escalating dosage of interferon alfa in patients with chronic hepatitis C.
Gastroenterology - 1 Jul 1995
Marcellin P, Pouteau M, Martinot-Peignoux M, Degos F, Duchatelle V, Boyer N, Lemonnier C, Degott C, Erlinger S, Benhamou J P
Abstract excerpt
BACKGROUND & AIMS: In patients with chronic hepatitis C treated with interferon alfa, sustained normalization of alanine aminotransferase was observed in about 20%, and no predictive factor of response could be clearly identified. The aims of this study were to assess the efficacy of an escalatin...
Topics
- Adolescent
- Adult
- Aged
- Chi-Square Distribution
- Chronic Disease
- Female
- Follow-Up Studies
- Genotype
- Hepacivirus
- Hepatitis Antibodies
- Hepatitis C
- Hepatitis C Antibodies
- Humans
- Interferon alpha-2
- Interferon-alpha
- Male
- Middle Aged
- Multivariate Analysis